Objectives-To evaluate the neurodevelopmental outcomes of very preterm (<30 weeks) infants who underwent tracheostomy.
neurologic impairment, profound hearing loss, severe visual impairment) at a corrected age of 18-22 months. Outcomes were compared using multiple logistic regression. We assessed impact of timing, by comparing outcomes of infants who underwent tracheostomy before and after 120 days of life.
Results-Tracheostomies were associated with all neonatal morbidities examined, and with most adverse neurodevelopmental outcomes. Death or NDI occurred in 83% of infants with tracheostomies and 40% of those without [odds ratio (OR) adjusted for center 7.0 (95%CI, ]. After adjustment for potential confounders, odds of death or NDI remained higher [OR 3.3 (95%CI, ], but odds of death alone were lower [OR 0.4 (95%CI, ], among infants with tracheostomies. Death or NDI was lower in infants who received their tracheostomies before, rather than after, 120 days of life [adjusted OR 0.5 (95%CI, ].
Conclusions-Tracheostomy in preterm infants is associated with adverse developmental outcomes, and cannot mitigate the significant risk associated with many complications of prematurity. These data may inform counseling about tracheostomy in this vulnerable population.
Keywords
newborn; very low birth weight infant; neurodevelopmental impairment; tracheotomy; bronchopulmonary dysplasia; prematurity Decisions about whether and when to place a tracheostomy in preterm infants who require prolonged ventilation or who have airway abnormalities are challenging. Most tracheostomies in children are performed in infants less than 12 months of age. (1) A few small studies document the incidence of mortality and airway morbidity after tracheostomy in young children. (2) (3) (4) Even more limited data are published on longer-term morbidities and neurodevelopmental outcomes. (5) (6) (7) (8) The most recent large, single-center cohort study of 165 infants with tracheostomies reported 3-year survival of 91%, but developmental delays in 64%. This study did not detail the timing or content of the developmental evaluations. (8) Very preterm infants have a high baseline risk for adverse long-term outcomes, and severe lung disease substantially increases this risk. (9, 10) It is unknown whether tracheostomy is independently associated with an increased risk for adverse outcomes in preterm infants. Moreover, optimal timing for tracheostomy is unknown. (11, 12) Such information could help inform clinicians when making decisions with families about the timing of tracheostomy placement, and planning for the care of these children throughout childhood.
We performed a cohort study to evaluate the outcomes of very preterm infants undergoing tracheostomy in the NICHD Neonatal Research Network (NRN) over a 10-year period. Our goals were to report the developmental outcomes of infants with tracheostomies who were evaluated in follow-up at 18-22 months corrected age, in comparison with the rest of the population of very preterm infants; and to evaluate whether timing of tracheostomy is related to outcomes.
Methods
The NRN uses a predefined protocol which prospectively collects medical and developmental follow-up data at 18-22 months corrected age on all infants born with birth weight 401-1000 grams (if born before 1/1/2008) or before 27 weeks gestation (if born on or after 1/1/2008). (13) The same protocol is used to collect follow-up data about children of any gestational age who are enrolled in an NRN clinical trial requiring neurodevelopmental follow-up. In the current analyses we evaluated outcomes of the cohort of infants who were born before 30 weeks of gestation, who survived to at least 36 weeks postmenstrual age and who were eligible for follow-up at one of the 16 centers that participated in the NRN from 2001 to 2011. Institutional Review Boards at each study center approved the collection of data during both the initial hospitalization and neonatal follow-up.
The primary outcome was a composite of two important competing outcomes: death or neurodevelopmental impairment (NDI) at 18-22 months. Standard definitions of NDI were used: NDI consisted of neurologic impairment, developmental delay, or visual or hearing impairment. (14, 15) By expert consensus, the definition of NDI evolved after the Bayley Scales of Infant Development-II were replaced by the Bayley-III. (16) (17) (18) (19) For children born before 1/1/2006, cutoffs for NDI were: neurologic impairment -moderate to severe cerebral palsy with Gross Motor Function Classification Scale (GMFCS) level of 2 or higher; developmental delay -Bayley-II Mental or Psychomotor Development Index (MDI or PDI) <70; visual impairment -<20/200 bilaterally; hearing impairment -bilateral amplification for permanent hearing loss. (20) Children born after 1/1/2006 were tested with the Bayley Scales of Infant Development-III. Cutoffs for NDI were: neurologic impairment -moderate to severe cerebral palsy; developmental delay: Bayley-III Cognitive or Motor score <85; visual impairment -limited with correction or blindness in one or both eyes; hearing impairment -permanent hearing loss that does not permit child to understand directions and communicate. An infant was considered to have NDI if one or more of the components of the composite outcome were known to be present, or unaffected if no component was present. If one or more components of NDI were missing and no component could be confirmed as abnormal, the primary outcome was deemed missing. To ensure that differences in primary outcomes could not be ascribed to the temporal change in testing regimens, a separate analysis was performed by time period of neurodevelopmental testing.
Secondary outcomes were the individual components of NDI, relationship between timing of tracheostomy and outcomes, results of the Brief Infant/Toddler Social and Emotional Assessment (BITSEA) scale and, for infants tested with the Bayley III, language scores with receptive and expressive language subscales. (17, 21, 22) Bronchopulmonary dysplasia (BPD) was defined as oxygen use at 36 weeks postmenstrual age. Both the presence and the severity of BPD are independently associated with cognitive impairment. (23, 24) Therefore, to measure the severity of BPD, we described "prolonged ventilation" as receipt of mechanical ventilation for more than the 75 th percentile (43 days). Brain injury was defined as intraparenchymal hemorrhage [Grade 4 intraventricular hemorrhage (IVH)], IVH with ventricular enlargement (Grade 3 IVH), or cystic periventricular leukomalacia on cranial ultrasound in the first 28 days. Severe retinopathy of prematurity (ROP) was defined as stage 3 or higher or any retinopathy that required treatment. Necrotizing enterocolitis (NEC) was defined as stage II or III, based on the modified Bell's staging criteria. (25) Infants were classified with malformations or syndromes if they were diagnosed with any major malformations, chromosomal abnormalities, or other syndromes with multi-organ involvement at any point during the hospitalization. Our data set allowed determination of "earlier" tracheostomy if infants received a tracheostomy prior to 120 days of life or "later" tracheostomy if they were subsequently coded as having a tracheostomy at the time of follow-up. All other infants were classified in the "no tracheostomy" group.
Statistical Analyses
We used traditional bivariate tests to compare baseline demographics and neonatal morbidities among infants with and without tracheostomies. We used t-tests for normally distributed continuous data, Poisson models for count data such as number of rehospitalizations, and chi-squared tests for dichotomous data. Odds of death or NDI, based on the presence of a tracheostomy at any time before follow-up, were evaluated with logistic regression. Regression models were first adjusted for center as a fixed effect. The analysis was then repeated with center and several additional pre-specified potential confounding variables. All of these variables were known to be independently correlated with survival or long-term developmental outcome. Variables fell into two groups: (1) baseline factorsbirth weight (as a continuous variable), sex, antenatal steroid exposure, race, presence of syndromes or major malformations, and (2) neonatal morbidities (as defined above) -brain injury, sepsis, NEC, severe ROP, surgical ligation of patent ductus arteriosus (PDA), and BPD. To ensure that the above described changes in the definition of NDI did not lead to spurious associations, time period was included in all models.
The same models were used to compare components of the primary outcome, Bayley-III language scores, and other developmental outcomes between the groups and to generate risk-adjusted probabilities. Subgroup analyses were performed to evaluate the effect of changing definitions of NDI on the primary outcome.
Finally, we planned to evaluate the effect of "Earlier" versus "Later" tracheostomy on outcome. Our database does not include procedure dates, but does indicate whether critical events (such as tracheostomy) occurred before or after 120 days of life. Therefore, we compared outcomes of patients who underwent tracheostomy prior to 120 days of life ("Earlier") with outcomes of those who underwent tracheostomy at any time between 120 days and follow-up ("Later").
Analyses were performed with SAS version 9.3 and p<0.05 was considered significant. No adjustments were made for multiple comparisons in this exploratory observational study.
Results
Over the study period (2001-2011), 10,128 children were born before 30 weeks gestation, survived to at least 36 weeks postmenstrual age, and were eligible for neonatal follow-up at 18-22 months corrected age in 16 NRN centers. We excluded 1,445 (14%) children because of missing data on the primary outcome, of whom 29 (2.0%) had tracheostomies. The remaining 8,683 children included 304 children (3.5%) with tracheostomies (Table I) . Infants who underwent tracheostomy had lower average birth weight and gestational age and were more likely to be male and have a congenital anomaly. Infants with tracheostomies had higher incidence of all in-hospital morbidities than those without tracheostomies (Table I) . There was no significant change in incidence of tracheostomy over the 10 years of this study (Wald χ 2 p=0.29). The proportion of children undergoing tracheostomy varied significantly across the 16 participating centers from 1% to 10% (Wald χ 2 p<0.001), likely reflecting differing referral and practice patterns. The average corrected age at which developmental testing was performed in survivors was the same in the two groups [median 19 months, interquartile range (16) (17) (18) (19) (20) (21) (22) , p=0.27].
Primary Outcome
Children with tracheostomies had significantly higher risk of the primary composite outcome of death or NDI and of all of the components of NDI (Table II) than children without tracheostomies. In an attempt to adjust for risk factors other than tracheostomy, we performed pre-specified analyses adjusted for 15 factors. Each of these is known to be associated with both risk for tracheostomy and risk for adverse neurodevelopmental outcomes, as described above. After adjustment, prevalence of the primary outcome of death or NDI, NDI, and the components of NDI remained substantially higher in children with tracheostomies than in those without tracheostomies (Table II) . The "fully adjusted" odds ratio (OR) of death or NDI in children with tracheostomies, compared with those without, was 3.3 (95% CI, 2.4-4.6), and the fully adjusted odds ratio of NDI in survivors with tracheostomies, compared to those without, was 4.0 (95% CI, 2.9-5.5). The Figure  summarizes graphically the elevated risk-adjusted probabilities of adverse outcomes in children with tracheostomies compared with those without tracheostomies.
After adjusting only for center, there was no difference between the groups in risk of death between 36 weeks postmenstrual age and 18-22 months (Table II) . However, in the fully risk-adjusted analyses, mortality was significantly lower in children with tracheostomies. To explore this unexpected result, post-hoc analysis in the full model, suggested that this difference was completely mediated by the inclusion of BPD and prolonged ventilation. One interpretation is that children with BPD who did not have tracheostomies had an increased risk of death.
Secondary Outcomes
Most other secondary developmental outcomes were significantly worse in the children with tracheostomies (Table III) . Although tracheostomy is expected to be associated with delays in expressive language, we observed a similar delay in receptive language skills. Only the "problem score" of the BITSEA was similar in the two groups, indicating that 18-22 month old children with tracheostomies are not at increased risk for social-emotional/behavioral problems. Nonetheless, children with tracheostomies appear to have higher risk for delays in social-emotional competence.
When definitions of NDI changed from Bayley-II to Bayley-III, there was a statistically significant decrease in the proportion of children who were classified as having NDI; 38% (2205/5803) of children tested with the Bayley-II were classified as having NDI compared with 36% (833/2314) of children tested with the Bayley-III (p=0.019). However, despite this difference, the change in definition of NDI did not reduce the highly significant association between tracheostomy and NDI (p<0.001).
Due to the limitations of our data set, the timing of tracheostomy could only be evaluated by whether it occurred before ("Earlier" n=132) or after ("Later" n=172) 120 days of life. In pre-specified analyses, as compared with all children without tracheostomy, fully adjusted odds ratio of death or NDI for children who underwent Earlier tracheostomy was 2.3 (95% CI, 1.5-3.5), whereas it was 4.7 (95% CI, 2.9-7.4) for children who underwent Later tracheostomy. The fully adjusted odds ratio for death or NDI in children who received Earlier tracheostomy, when compared with those who received Later tracheostomy, was 0.5 (95% CI, 0.3-0.9).
Discussion
This retrospective study of prospectively collected data cannot establish causality, but merely suggest plausible associations. However, this cohort is unique in several ways. We evaluated mortality and neurodevelopmental outcomes at 18-22 months corrected age in children who were born at less than 30 weeks gestation and underwent tracheostomy placement. Prior smaller, mostly single center studies of children with tracheostomies did not include comparison groups without tracheostomies. In contrast, our large data set was collected in a standard protocol at 16 sites over a 10-year period and includes comparison with the larger population of preterm infants without tracheostomies.
In our cohort, tracheostomy was associated with a significantly increased risk for the composite primary outcome of death or NDI. Because of the many known risk factors for adverse developmental outcome and survival in preterms, we performed a number of apriori risk adjustments. Even after adjusting for 17 factors predictive of adverse outcome, children with tracheostomies still had significantly increased odds of adverse developmental outcomes. Although tracheostomy might itself put children at risk for poor outcomes, such a causal relationship is less likely than a non-causal association between tracheostomy and significantly increased risk for poor outcome. It is more likely that we have not fully controlled for confounding by indication, despite a 17 factor adjustment. It is likely that the need for tracheostomy itself defines a risk for adverse outcome that is not wholly captured by the risk factors included. In other words, tracheostomy may be a marker for risk. These limitations of our statistical models do not change the importance of our results. Clinicians considering a tracheostomy for an individual patient could supplement clinical status and history with these data to help parents grasp potential long term outcomes.
Although only a minority of preterm infants ultimately undergo tracheostomy placement, the paucity of relevant literature makes decisions about this procedure very challenging. Reports of complications following pediatric and infant tracheostomy have almost exclusively described indications, mortality, and airway related complications. (26) (27) (28) (29) (30) (31) A few older studies reported intellectual disabilities and language delays in children requiring tracheostomies. (5, 6, (32) (33) (34) In 1974, children who received tracheostomies early in life were reported to be "withdrawn in character and of poor academic and recreational standard."(35) Singer reported developmental outcomes at an average of 5 years in a cohort of 130 infants from 2 hospitals who received tracheostomies before 13 months of age during 1972-82. (6) Twenty-nine percent died before follow-up and 45% of survivors were classified with mental retardation or neurological handicap. In a single-center study of 41 infants with tracheostomies, 83% required tube feedings, 97% had abnormal muscle tone, 36% had cerebral palsy, and 24% required hearing aids at a mean age of 27 months. (7) Among those evaluated after 12 months of age, only 16% had average skills and 68% had significant developmental delays. In a questionnaire-based study of functional status in former very preterm infants with tracheostomies, parents reported deterioration over time, especially in the areas of responsiveness, activity, and interpersonal functioning. (36) Finally, a recent single-center series reported that 64% of 165 children with tracheostomies had "some degree of developmental delay," without defining "delay" or describing when or how these delays were identified. (8) We undertook the current study because these existing series cannot be generalized beyond their centers, have not adjusted for any of the known confounders of neurodevelopmental outcome in this population, and do not contain comparisons with children without this major complication of prematurity. Our results support prior reports of high risk for adverse outcomes in this population, even after consideration of multiple factors that put children at risk for poor long-term outcomes. This study also provides estimates of the prevalence of these outcomes in preterm children with tracheostomies. The 8% mortality that we report is lower than the mortality reported in older studies, which report mortality as high as 59%. (2, 3, 30, 37) Our results suggest a possible association between Earlier (<120 days) tracheostomy and better neurodevelopmental outcomes. This result supports the work of several authors who have recently suggested that, in older children and adults, tracheostomy placement should be performed as soon as possible. (8, 38, 39) We speculate that while an infant awaits a tracheostomy, the medical focus is often on strategies to enable weaning and limit ventilator-associated lung injury. Following a tracheostomy, the focus may shift to maximizing parent-child interaction and developmental enrichment. Furthermore, there is often opportunity to wean off of sedating medications, which may be associated with increased risk of NDI, after tracheostomy. (40) Importantly, severity of illness, indication for tracheostomy, anesthetic exposure, or other factors could have influenced either the timing of tracheostomy or developmental outcomes, leading to potential for bias. Therefore, prospective confirmation of this temporal relationship is essential before clinicians can confidently counsel parents toward earlier decisions about tracheostomy placement.
Long-term ventilation secondary to BPD is the most common indication for tracheostomy in preterm infants. (5, 11, 12) Both the presence and the severity of BPD strongly influence neurodevelopmental outcomes. (24) Because data for the "physiologic definition" of BPD were not available for the majority of patients in the current study, we instead used oxygen dependence at 36 weeks and prolonged mechanical ventilation as markers of the presence and severity of lung disease. (41, 42) As expected, poor outcomes were strongly correlated with both of these measures. Unexpectedly, the observed differences in the fully adjusted odds of mortality after 36 weeks were strongly associated with death of children with BPD who did not undergo tracheostomy. As discussed above, it remains possible that we have not adequately controlled for the impact of lung disease on long-term outcomes, or that clinicians offered therapy selectively. Nonetheless, because the majority of infants who undergo tracheostomy have severe BPD, our results remain relevant and applicable to these children.
Comparing neurodevelopmental outcomes in children who were tested with different editions of the Bayley Scales of Infant Development is a recent challenge in neonatal follow-up. (18, 19) We decided a priori to use the existing NRN definitions of NDI, recognizing that the different tests and definitions might capture slightly different outcomes. However, both the proportion of children who were diagnosed with NDI and the association of tracheostomy with NDI were relatively consistent over time. An additional limitation of using the Bayley Scales of Infant Development at 18-22 months is the increased recognition that assessments at this early time point do not predict school age functioning, except perhaps in the most severely affected children. (43) (44) (45) (46) (47) Many children classified as mildlymoderately impaired as toddlers demonstrate gains in cognitive performance when reevaluated at older ages. (43, 44) Unfortunately, data about school-age outcomes are not available for this or any other large cohort of children with tracheostomies.
We acknowledge several additional limitations of this large observational study. Firstly, attrition bias is possible because we are unable to ascertain the primary outcome in 14% of eligible children and attrition was higher among children without tracheostomies. Selection bias may have been introduced either by clinical decisions about which infants received tracheostomies or by the inclusion of only survivors to 36 weeks in the current study. Lastly, we emphasize again that we can only describe an association between the need for tracheostomy and adverse outcomes. The child who ultimately requires tracheostomy placement will have accumulated multiple risk factors for adverse outcome, some of which we were able to include in our analyses and some of which must be considered unmeasured confounders. Thus, the need for tracheostomy must suggest to clinicians that a patient's severity of illness puts that patient at extremely high risk for adverse long-term outcomes.
In conclusion, this is the first large, multicenter study to describe the long-term neurodevelopmental outcomes of preterm infants with tracheostomies with comparison with the general preterm population. Tracheostomy does not mitigate the significant risk for adverse neurodevelopment that is associated with multiple neonatal morbidities, major malformations, or severe BPD. However, if tracheostomy is to be performed, earlier surgery may allow opportunities for enhanced neurodevelopment. Information about the association between tracheostomy placement and outcomes in this population may facilitate a shared decision-making process between parents and clinicians about whether and when to pursue tracheostomy placement.
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Figure. Risk-Adjusted Probabilities of Components of Neurodevelopmental Impairment and Bayley Scales of Infant Development, by Tracheostomy
Error bars represent 95% confidence intervals for risk-adjusted probabilities. Probabilities were adjusted for center, time period, birth weight, sex, antenatal steroid exposure, race, presence of syndromes or major malformations, brain injury, sepsis, NEC, severe ROP, surgical ligation of PDA, BPD (oxygen dependence at 36 weeks) and prolonged ventilation. Language delay is defined as <85 (ie, >1 standard deviation below the expected mean score of 100, on the language scale of the Bayley Scales of Infant Development-III). Neurologic delay is defined as moderate to severe cerebral palsy with GMFCS level of 2 or higher. 
